DS

Dnyaneshwari Shailesh Dalal

Active Director Director DIN 10404070
DIN 10404070 First appointment Nov 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Dnyaneshwari Shailesh Dalal

Data last updated:

Dnyaneshwari Shailesh Dalal is a Director at Coscutem Pharmaceuticals Private Limited (since 2023). The company operates in Pharma.

DIN 10404070
Primary Designation Director
Industry Pharma
First Appointment 24 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Nov 20232023Active

Board colleagues of Dnyaneshwari Shailesh Dalal

Directorship timeline

Open interactive timeline →
Coscutem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Dnyaneshwari Shailesh Dalal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dnyaneshwari Shailesh Dalal

Dnyaneshwari Shailesh Dalal currently holds 1 directorship: Coscutem Pharmaceuticals Private Limited (Director, since 24 Nov 2023).

Dnyaneshwari Shailesh Dalal was first appointed on 24 Nov 2023 as Director at Coscutem Pharmaceuticals Private Limited.

The current boards of Dnyaneshwari Shailesh Dalal's companies include Sanket Vishwanath Sontakke (Coscutem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available